FDA to create inter-center ad group
FDA is forming an inter-center group to oversee advertising policies for different products regulated by FDA, Acting Commissioner Lester Crawford, PhD, announces Aug. 2 at a National Press Club luncheon in Washington, D.C. FDA will issue guidance on outdoor advertising, comparative claims and implied claims later this year, he adds. The agency released three draft guidances related to direct-to-consumer advertising in February (1"The Pink Sheet" Feb. 9, 2004, p. 3)...
You may also be interested in...
FDA is forming an inter-center group to oversee advertising policies for different products regulated by the agency, Acting Commissioner Lester Crawford announced at a recent National Press Club luncheon in Washington, D.C
FDA's publication of three draft guidances on direct-to-consumer advertising is unlikely to relieve pressure on the agency to explain its approach to enforcement actions against drug manufacturers that repeatedly run false and misleading promotions
Sanofi has deprioritized its presence in type 1 diabetes in recent years but could help turn teplizumab into a game-changer blockbuster product.